Literature DB >> 10773103

Serum isoforms of bone alkaline phosphatase increase during physical exercise in women.

A Rudberg1, P Magnusson, L Larsson, H Joborn.   

Abstract

Physical activity is an important factor for maintaining and probably increasing bone mass in humans. However, the mechanism by which this takes place is not completely understood. The purpose of this study was to examine the influence of physical exercise on serum alkaline phosphatase (ALP) and in particular, the bone isoforms of ALP. Six ALP isoforms were quantified by high-performance liquid chromatography: three bone (B/I, B1, and B2), and three liver ALP isoforms. In addition, serum calcium, parathyroid hormone (PTH), and other markers of bone formation and degradation, as measured by osteocalcin and cross-linked carboxyterminal telopeptide of type I collagen (ICTP), were analyzed. The study groups comprised 15 women, 8 postmenopausal (range 51-62 years) and 7 near age of peak bone mass (range 21-27 years). When the postmenopausal women exercised on an ergometer cycle until exhaustion we found significant increases in serum of bone ALP isoforms B1 and B2, and phosphate, even considering the hemoconcentration that occurred during the exercise. When the young women jogged in a moderate tempo for 40-40 minutes the levels of serum B2 and PTH increased. All changes turned towards baseline within 20 minutes after exercise. In conclusion, exercise increased serum ALP bone isoforms B1 and B2, and their responses were differentiated. As B1 and B2 are known to represent specific bone compartments, cortical and trabecular bone, the present findings may indicate different effects on bone of weight- and nonweight-bearing exercise.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10773103     DOI: 10.1007/s002230010071

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  7 in total

Review 1.  Bone metabolism markers in sports medicine.

Authors:  Giuseppe Banfi; Giovanni Lombardi; Alessandra Colombini; Giuseppe Lippi
Journal:  Sports Med       Date:  2010-08-01       Impact factor: 11.136

2.  The Bone Biomarker Response to an Acute Bout of Exercise: A Systematic Review with Meta-Analysis.

Authors:  Eimear Dolan; Alina Dumas; Karen M Keane; Giulia Bestetti; Luisa Helena Mavalli Freitas; Bruno Gualano; Wendy M Kohrt; George A Kelley; Rosa Maria Rodrigues Pereira; Craig Sale; Paul A Swinton
Journal:  Sports Med       Date:  2022-07-23       Impact factor: 11.928

3.  Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass.

Authors:  Gabriella Császárné Gombos; Viktória Bajsz; Emese Pék; Béla Schmidt; Eszter Sió; Bálint Molics; József Betlehem
Journal:  BMC Musculoskelet Disord       Date:  2016-06-08       Impact factor: 2.362

4.  The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-Blind, Placebo-Controlled, Randomized Clinical Trial.

Authors:  Paula Dakin; Stephen J DiMartino; Haitao Gao; Jennifer Maloney; Alan J Kivitz; Thomas J Schnitzer; Neil Stahl; George D Yancopoulos; Gregory P Geba
Journal:  Arthritis Rheumatol       Date:  2019-09-20       Impact factor: 10.995

5.  Associations of aerobic and strength exercise with clinical laboratory test values.

Authors:  Maren S Fragala; Caixia Bi; Michael Chaump; Harvey W Kaufman; Martin H Kroll
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

Review 6.  Undercarboxylated Osteocalcin: Experimental and Human Evidence for a Role in Glucose Homeostasis and Muscle Regulation of Insulin Sensitivity.

Authors:  Xuzhu Lin; Tara C Brennan-Speranza; Itamar Levinger; Bu B Yeap
Journal:  Nutrients       Date:  2018-06-29       Impact factor: 5.717

Review 7.  The time course and mechanisms of change in biomarkers of joint metabolism in response to acute exercise and chronic training in physiologic and pathological conditions.

Authors:  Harry M Roberts; Rebecca-Jane Law; Jeanette M Thom
Journal:  Eur J Appl Physiol       Date:  2019-10-24       Impact factor: 3.078

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.